Dragonfly Biosciences discusses plans to list on ASX
Regan Saveall, CEO of leading UK CBD company Dragonfly Biosciences, discusses the company and its plans to list on the ASX in August. Paul Sanger: Today, I’m joined by Regan Saveall, Executive Director and CEO of Dragonfly Biosciences. Dragonfly is a vertically integrated, seed-to-shelf CBD business that trades under the Dragonfly CBD brand. The company […]
Dragonfly Biosciences discusses plans to list on ASX Read More »
